Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

33%

Ph not_applicable

33%

Ph phase_4

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Terminated(2)

Detailed Status

Withdrawn2

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (33.3%)

Phase 41 (33.3%)

N/A1 (33.3%)

Trials by Status

withdrawn267%

completed133%

Recent Activity

0 active trials

Showing 3 of 3

withdrawnphase_1

Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer

NCT06094842

completedphase_4

Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency

NCT04410536

withdrawnnot_applicable

Mitigation of Emergence Agitation Through Implementation of Masimo Bridge Therapy

NCT06387953

Clinical Trials (3)

Showing 3 of 3 trials

NCT06094842Phase 1

Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer

Withdrawn

NCT04410536Phase 4

Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency

Completed

NCT06387953Not Applicable

Mitigation of Emergence Agitation Through Implementation of Masimo Bridge Therapy

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3